Category: Oncology/Hematology
Oncology/Hematology market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics This study covers the world outlook for non-small cell lung cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for Oncology Molecular Diagnostics
The 2025-2030 World Outlook for Oncology Molecular Diagnostics This study covers the world outlook for oncology molecular diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Prostate Cancer Therapeutics
The 2025-2030 World Outlook for Prostate Cancer Therapeutics This study covers the world outlook for prostate cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Prostate Cancer Treatments
The 2025-2030 World Outlook for Prostate Cancer Treatments This study covers the world outlook for prostate cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Pancreatic Cancer Treatments
The 2025-2030 World Outlook for Pancreatic Cancer Treatments This study covers the world outlook for pancreatic cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Cancer-Treating Drugs
The 2025-2030 World Outlook for Cancer-Treating Drugs This study covers the world outlook for cancer-treating drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Pancreatic Cancers
The 2025-2030 World Outlook for Pancreatic Cancers This study covers the world outlook for pancreatic cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Liver Cancer Diagnostics
The 2025-2030 World Outlook for Liver Cancer Diagnostics This study covers the world outlook for liver cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Liver Cancer Drugs
The 2025-2030 World Outlook for Liver Cancer Drugs This study covers the world outlook for liver cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Prostate Cancers
The 2025-2030 World Outlook for Prostate Cancers This study covers the world outlook for prostate cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Prostate Cancer Treatments and Prevention
The 2025-2030 World Outlook for Prostate Cancer Treatments and Prevention This study covers the world outlook for prostate cancer treatments and prevention across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Drugs
The 2025-2030 World Outlook for Breast Cancer Drugs This study covers the world outlook for breast cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Cancer Immunotherapy Drug Discovery Outsourcing
The 2025-2030 World Outlook for Cancer Immunotherapy Drug Discovery Outsourcing This study covers the world outlook for cancer immunotherapy drug discovery outsourcing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More
-
The 2025-2030 World Outlook for Head and Neck Oncology Nutrition
The 2025-2030 World Outlook for Head and Neck Oncology Nutrition This study covers the world outlook for head and neck oncology nutrition across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Cancer Vaccines
The 2025-2030 World Outlook for Cancer Vaccines This study covers the world outlook for cancer vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2025-2030 World Outlook for Cutaneous Melanoma Therapeutics
The 2025-2030 World Outlook for Cutaneous Melanoma Therapeutics This study covers the world outlook for cutaneous melanoma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Hematological Cancer Treatments
The 2025-2030 World Outlook for Hematological Cancer Treatments This study covers the world outlook for hematological cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Squamous Cell Carcinoma of the Head and Neck Treatments
The 2025-2030 World Outlook for Squamous Cell Carcinoma of the Head and Neck Treatments This study covers the world outlook for squamous cell carcinoma of the head and neck treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indu ... Read More
-
The 2025-2030 World Outlook for Genomics in Cancer Care
The 2025-2030 World Outlook for Genomics in Cancer Care This study covers the world outlook for genomics in cancer care across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Precision Cancer Diagnostics
The 2025-2030 World Outlook for Precision Cancer Diagnostics This study covers the world outlook for precision cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Gastric Cancer Monoclonal Antibodies (mAb)
The 2025-2030 World Outlook for Gastric Cancer Monoclonal Antibodies (mAb) This study covers the world outlook for gastric cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2025-2030 World Outlook for Melanoma Scanners
The 2025-2030 World Outlook for Melanoma Scanners This study covers the world outlook for melanoma scanners across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Thyroid Cancer Drugs
The 2025-2030 World Outlook for Thyroid Cancer Drugs This study covers the world outlook for thyroid cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Progestogens for Cancer Cachexia
The 2025-2030 World Outlook for Progestogens for Cancer Cachexia This study covers the world outlook for progestogens for cancer cachexia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Urological Cancers
The 2025-2030 World Outlook for Urological Cancers This study covers the world outlook for urological cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
Research Assistance
